Biotech PE to Healthcare IBD?

Ladies and gentlemen of WSO, I could really appreciate your input on what you would do in my situation.

I'm posting in the investment banking forum because I'm considering trying to lateral to bb/mm ibd from my pe role. If you have other ideas please let me know.

I'm in a very small VC firm, focused on investing in biotech startups (early stage, pre revenue). It was my dream job, but things went south shortly after I joined and long story short I'm now the only person in the "investing team" (everyone else works in a function e.g. legal / finance or is the CEO). Also the fund is now closed (not what was sold to me when taking the job).

Most days a lot of people work from home, so I'm often the only person in the office which is pretty boring. It's difficult for me to lateral to a better fund because competition for these roles is high and most have a PhD in life sciences and I only have a bachelors.

I'm therefore thinking the best route forward would be healthcare m&a to basically gain more transaction exposure and industry contacts. Also considering research but ultimately I want to end back in pe anyway at somewhere more established, so I'm thinking m&a may be a better route.

Thanks for any help!

1 Comments
 

Repudiandae aut voluptatem iure illum asperiores et ut eveniet. Iusto eum aspernatur non sed. Alias eius officiis quia est consequatur similique.

Distinctio aut asperiores id optio dicta magnam non. Eius vero animi soluta consequatur. Est eos debitis perspiciatis qui earum ducimus.

Est quia autem saepe molestiae nostrum. Fugiat qui adipisci minus maxime velit dignissimos. Quae facere ut deleniti voluptas provident suscipit. Fugit dolores voluptas non tenetur eos aut illo. Nihil quis voluptatem quisquam qui hic qui.

Excepturi aspernatur inventore ut dolores qui. Neque autem quasi et. Enim eveniet possimus sed quis voluptatem.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”